Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BY-NC-ND 4.0Cardio-oncology

Integrating coronary artery calcium scoring into radiotherapy planning CT scans to guide cardio-oncology referral in cancer patients: a multicentre prospective feasibility study

7 affiliations
  1. 1Department of Radiation Oncology, Genesis Care Pty Ltd., Perth, WA Australia
  2. 2Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, VIC Australia
  3. 3Nutrition and Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA Australia
  4. 4Advara HeartCare, Adelaide, South Australia Australia
  5. 5School of Medicine, University of Adelaide, Adelaide, South Australia Australia
  6. 6Advara HeartCare, Perth, WA Australia
  7. 7Department of Radiation Oncology, Sir Charles Gardiner Hospital, Perth, WA Australia

Abstract

Background: As cancer survival rates improve, focus has moved toward managing long-term treatment-related toxicities such as cardiovascular disease (CVD). Radiation is an important modality of treatment for many cancers; however, its use can lead to cardiovascular disease by accelerating the formation of coronary artery atherosclerosis. Coronary artery calcium (CAC) scoring from computed tomography (CT) scans offer a non-invasive method to assess CVD risk. Cancer patients undergoing thoracic radiotherapy require a CT scan of the chest for planning purposes. The primary aim of this study was to assess the feasibility of using radiotherapy planning CT scans to calculate CAC scores in cancer patients and establish a cardio-oncology referral pathway. Secondary aims were to evaluate the impact of CAC scoring on anxiety and quality of life (QoL); and assess adherence to cardio-oncology referral pathway.

Methods: A multicentre, prospective observational study recruited 101 eligible cancer survivors (predominantly women with breast cancer) undergoing thoracic radiotherapy. CAC scores were calculated from planning CT scans, and participants with CAC > 0 were referred to cardio-oncology. QoL and anxiety were measured at baseline, shortly after CAC disclosure, and three months post-radiotherapy. Adherence to cardio-oncology referrals was recorded.

Results: CAC scores were successfully calculated for all participants; 31% had a CAC score > 0. Of those, 87% were referred to cardio-oncology and 96% of referred participants attended their appointments. Survivors with CAC > 0 had lower QoL at all timepoints, but disclosure of CAC scores did not significantly affect anxiety or QoL over time. Anxiety decreased post-disclosure in both groups.

Conclusions: CAC scoring from radiotherapy planning CT scans is a feasible method to identify cancer survivors at elevated CVD risk. High adherence to follow-up and stable anxiety and QoL outcomes support its integration into routine cancer care. Future studies are needed to determine whether early cardiac intervention improves long-term outcomes.

Trial registration: Ethics approval was granted by St Vincent’s Hospital (Sydney) Human Research Ethics Committee (HREC) (Project number 2021/ ETH11847). Regulatory review approval was granted by GenesisCare, and governance approval was granted by the Edith Cowan University HREC (202203326DALLAVIA).

Governance approval was granted by GenesisCare and the trial was registered with Australian New Zealand Clinical Trials Registry (registration number ACTRN12621001343897p), registration date 7th October 2021.

Related

  1. Radiotherapy dose escalation for the non-operative management of patients with unresectable locally recurrent rectal cancer (STEP-UP): Study protocol for a multicentre, prospective, open-label feasibility study.
    F E C Vande Kerckhove, J L Beeftink, R H N Tijssen +19
    Clinical and translational radiation oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  2. 5T Non-Contrast One-Stop MRA for Thoracic Aorta and Coronary Arteries: A Prospective Feasibility Study in Healthy Volunteers
    Yan Xu, Chuangwei Wei, Runzhi Zhang +7
    Journal of cardiovascular development and diseasePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Diagnostic Accuracy and Feasibility of Quantitative Flow Ratio at Low Frame Rate Angiography: The Prospective Multicentre Australian AVALON Study
    Joseph M. O'Brien, Michael Zhang, Thomas J. Ford +11
    Catheterization and Cardiovascular InterventionsPeer-reviewedCC BY-NC 4.0Full textSurgery & anaesthesiaPMC
  4. Establishing a national platform to facilitate patient recruitment and advanced diagnostics for cancer immunotherapies (the NHS Cancer Vaccine Launch Pad): a multicentre prospective cohort feasibility study protocol
    Benjamin Moxley-Wyles, Nicole Keyworth, Victoria M Goss +24
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textOncologyCrossrefPMC
  5. Associations of clinical frailty and the triglyceride-glucose index with major adverse cardiovascular events in older adults with acute coronary syndrome in southern Vietnam: a prospective multicentre cohort study
    Phuc Thien Tran, Huan Thanh Nguyen, Nghia Thuong Nguyen +8
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textGeneral medicineCrossrefPMC
BibTeX
@article{stewart2026integrating,
  title = {{Integrating coronary artery calcium scoring into radiotherapy planning CT scans to guide cardio-oncology referral in cancer patients: a multicentre prospective feasibility study}},
  author = {Nina Stewart and Jack Dalla Via and Daniel A. Cehic and Peter Purnell and Mary A. Kennedy and Jamie Morton and Melissa du Heaume and Yvonne Zissiadis},
  journal = {Cardio-oncology},
  year = {2026},
  month = aug,
  doi = {10.1186/s40959-026-00557-0},
  url = {https://doi.org/10.1186/s40959-026-00557-0},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Integrating coronary artery calcium scoring into radiotherapy planning CT scans to guide cardio-oncology referral in cancer patients: a multicentre prospective feasibility study
AU  - Nina Stewart
AU  - Jack Dalla Via
AU  - Daniel A. Cehic
AU  - Peter Purnell
AU  - Mary A. Kennedy
AU  - Jamie Morton
AU  - Melissa du Heaume
AU  - Yvonne Zissiadis
PY  - 2026
DA  - 2026/08/13
JO  - Cardio-oncology
DO  - 10.1186/s40959-026-00557-0
UR  - https://doi.org/10.1186/s40959-026-00557-0
AB  - Background: As cancer survival rates improve, focus has moved toward managing long-term treatment-related toxicities such as cardiovascular disease (CVD). Radiation is an important modality of treatment for many cancers; however, its use can lead to cardiovascular disease by accelerating the formation of coronary artery atherosclerosis. Coronary artery calcium (CAC) scoring from computed tomography (CT) scans offer a non-invasive method to assess CVD risk. Cancer patients undergoing thoracic radiotherapy require a CT scan of the chest for planning purposes. The primary aim of this study was to assess the feasibility of using radiotherapy planning CT scans to calculate CAC scores in cancer patients and establish a cardio-oncology referral pathway. Secondary aims were to evaluate the impact of CAC scoring on anxiety and quality of life (QoL); and assess adherence to cardio-oncology referral pathway.  Methods: A multicentre, prospective observational study recruited 101 eligible cancer survivors (predominantly women with breast cancer) undergoing thoracic radiotherapy. CAC scores were calculated from planning CT scans, and participants with CAC > 0 were referred to cardio-oncology. QoL and anxiety were measured at baseline, shortly after CAC disclosure, and three months post-radiotherapy. Adherence to cardio-oncology referrals was recorded.  Results: CAC scores were successfully calculated for all participants; 31% had a CAC score > 0. Of those, 87% were referred to cardio-oncology and 96% of referred participants attended their appointments. Survivors with CAC > 0 had lower QoL at all timepoints, but disclosure of CAC scores did not significantly affect anxiety or QoL over time. Anxiety decreased post-disclosure in both groups.  Conclusions: CAC scoring from radiotherapy planning CT scans is a feasible method to identify cancer survivors at elevated CVD risk. High adherence to follow-up and stable anxiety and QoL outcomes support its integration into routine cancer care. Future studies are needed to determine whether early cardiac intervention improves long-term outcomes.  Trial registration: Ethics approval was granted by St Vincent’s Hospital (Sydney) Human Research Ethics Committee (HREC) (Project number 2021/ ETH11847). Regulatory review approval was granted by GenesisCare, and governance approval was granted by the Edith Cowan University HREC (202203326DALLAVIA).  Governance approval was granted by GenesisCare and the trial was registered with Australian New Zealand Clinical Trials Registry (registration number ACTRN12621001343897p), registration date 7th October 2021.
SN  - 2057-3804
ER  -